Logo image of LUCD

LUCID DIAGNOSTICS INC (LUCD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:LUCD - US54948X1090 - Common Stock

1.13 USD
0 (0%)
Last: 1/6/2026, 8:00:00 PM
1.13 USD
0 (0%)
After Hours: 1/6/2026, 8:00:00 PM
Fundamental Rating

2

Taking everything into account, LUCD scores 2 out of 10 in our fundamental rating. LUCD was compared to 185 industry peers in the Health Care Equipment & Supplies industry. LUCD may be in some trouble as it scores bad on both profitability and health. LUCD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LUCD has reported negative net income.
In the past year LUCD has reported a negative cash flow from operations.
LUCD had negative earnings in each of the past 5 years.
In the past 5 years LUCD always reported negative operating cash flow.
LUCD Yearly Net Income VS EBIT VS OCF VS FCFLUCD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

LUCD has a worse Return On Assets (-123.77%) than 84.86% of its industry peers.
LUCD has a Return On Equity of -254.86%. This is in the lower half of the industry: LUCD underperforms 74.59% of its industry peers.
Industry RankSector Rank
ROA -123.77%
ROE -254.86%
ROIC N/A
ROA(3y)-179.51%
ROA(5y)-192.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LUCD Yearly ROA, ROE, ROICLUCD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

1.3 Margins

LUCD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LUCD Yearly Profit, Operating, Gross MarginsLUCD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -5K -10K

More info and screens

2

2. Health

2.1 Basic Checks

LUCD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LUCD has more shares outstanding
Compared to 5 years ago, LUCD has more shares outstanding
The debt/assets ratio for LUCD has been reduced compared to a year ago.
LUCD Yearly Shares OutstandingLUCD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
LUCD Yearly Total Debt VS Total AssetsLUCD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -5.91, we must say that LUCD is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of LUCD (-5.91) is worse than 72.43% of its industry peers.
A Debt/Equity ratio of 0.86 indicates that LUCD is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.86, LUCD is not doing good in the industry: 73.51% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF N/A
Altman-Z -5.91
ROIC/WACCN/A
WACC9.62%
LUCD Yearly LT Debt VS Equity VS FCFLUCD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

LUCD has a Current Ratio of 1.90. This is a normal value and indicates that LUCD is financially healthy and should not expect problems in meeting its short term obligations.
LUCD's Current ratio of 1.90 is on the low side compared to the rest of the industry. LUCD is outperformed by 63.24% of its industry peers.
LUCD has a Quick Ratio of 1.88. This is a normal value and indicates that LUCD is financially healthy and should not expect problems in meeting its short term obligations.
LUCD has a Quick ratio (1.88) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.88
LUCD Yearly Current Assets VS Current LiabilitesLUCD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

6

3. Growth

3.1 Past

LUCD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.12%, which is quite impressive.
LUCD shows a small growth in Revenue. In the last year, the Revenue has grown by 5.01%.
Measured over the past years, LUCD shows a very strong growth in Revenue. The Revenue has been growing by 105.61% on average per year.
EPS 1Y (TTM)22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)5.01%
Revenue growth 3Y105.61%
Revenue growth 5YN/A
Sales Q2Q%3.33%

3.2 Future

LUCD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.96% yearly.
LUCD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 75.37% yearly.
EPS Next Y33.6%
EPS Next 2Y29.38%
EPS Next 3Y20.77%
EPS Next 5Y11.96%
Revenue Next Year3.8%
Revenue Next 2Y60.26%
Revenue Next 3Y76.81%
Revenue Next 5Y75.37%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LUCD Yearly Revenue VS EstimatesLUCD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
LUCD Yearly EPS VS EstimatesLUCD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

LUCD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LUCD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LUCD Price Earnings VS Forward Price EarningsLUCD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LUCD Per share dataLUCD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

LUCD's earnings are expected to grow with 20.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.38%
EPS Next 3Y20.77%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LUCD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

LUCID DIAGNOSTICS INC

NASDAQ:LUCD (1/6/2026, 8:00:00 PM)

After market: 1.13 0 (0%)

1.13

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)03-23 2026-03-23/amc
Inst Owners27.81%
Inst Owner Change0%
Ins Owners5.64%
Ins Owner Change0.27%
Market Cap147.94M
Revenue(TTM)4.40M
Net Income(TTM)-65.84M
Analysts83.33
Price Target3.87 (242.48%)
Short Float %5.07%
Short Ratio6.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.11%
Min EPS beat(2)11.04%
Max EPS beat(2)35.18%
EPS beat(4)3
Avg EPS beat(4)-42.23%
Min EPS beat(4)-222.25%
Max EPS beat(4)35.18%
EPS beat(8)4
Avg EPS beat(8)-28.03%
EPS beat(12)6
Avg EPS beat(12)-15.73%
EPS beat(16)7
Avg EPS beat(16)-15.95%
Revenue beat(2)0
Avg Revenue beat(2)-6.34%
Min Revenue beat(2)-12.5%
Max Revenue beat(2)-0.17%
Revenue beat(4)0
Avg Revenue beat(4)-16.73%
Min Revenue beat(4)-36.75%
Max Revenue beat(4)-0.17%
Revenue beat(8)1
Avg Revenue beat(8)-12.2%
Revenue beat(12)2
Avg Revenue beat(12)-11.77%
Revenue beat(16)2
Avg Revenue beat(16)-24.93%
PT rev (1m)1.11%
PT rev (3m)2.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.45%
EPS NY rev (1m)0%
EPS NY rev (3m)2.61%
Revenue NQ rev (1m)-2.11%
Revenue NQ rev (3m)-2.11%
Revenue NY rev (1m)-1%
Revenue NY rev (3m)-2.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 33.63
P/FCF N/A
P/OCF N/A
P/B 5.73
P/tB 5.82
EV/EBITDA N/A
EPS(TTM)-0.88
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0.03
BVpS0.2
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -123.77%
ROE -254.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-179.51%
ROA(5y)-192.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 45.76%
Cap/Sales 9.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.9
Quick Ratio 1.88
Altman-Z -5.91
F-Score4
WACC9.62%
ROIC/WACCN/A
Cap/Depr(3y)37.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)87.81%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y33.6%
EPS Next 2Y29.38%
EPS Next 3Y20.77%
EPS Next 5Y11.96%
Revenue 1Y (TTM)5.01%
Revenue growth 3Y105.61%
Revenue growth 5YN/A
Sales Q2Q%3.33%
Revenue Next Year3.8%
Revenue Next 2Y60.26%
Revenue Next 3Y76.81%
Revenue Next 5Y75.37%
EBIT growth 1Y-6.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-10.07%
EBIT Next 3Y6.31%
EBIT Next 5Y4.51%
FCF growth 1Y-61.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.54%
OCF growth 3YN/A
OCF growth 5YN/A

LUCID DIAGNOSTICS INC / LUCD FAQ

What is the fundamental rating for LUCD stock?

ChartMill assigns a fundamental rating of 2 / 10 to LUCD.


Can you provide the valuation status for LUCID DIAGNOSTICS INC?

ChartMill assigns a valuation rating of 1 / 10 to LUCID DIAGNOSTICS INC (LUCD). This can be considered as Overvalued.


What is the profitability of LUCD stock?

LUCID DIAGNOSTICS INC (LUCD) has a profitability rating of 0 / 10.


What is the expected EPS growth for LUCID DIAGNOSTICS INC (LUCD) stock?

The Earnings per Share (EPS) of LUCID DIAGNOSTICS INC (LUCD) is expected to grow by 33.6% in the next year.